In the latest trading session,, 2.77 million NLS Pharmaceutics Ltd (NASDAQ:NLSP) shares changed hands as the company’s beta touched -0.09. With the company’s most recent per share price at $1.60 changed hands at -$0.11 or -6.43% at last look, the market valuation stands at $5.75M. NLSP’s current price is a discount, trading about -1049.37% off its 52-week high of $18.39. The share price had its 52-week low at $1.30, which suggests the last value was 18.75% up since then. When we look at NLS Pharmaceutics Ltd’s average trading volume, we note the 10-day average is 51040.0 shares, with the 3-month average coming to 71.49K.
Analysts gave the NLS Pharmaceutics Ltd (NLSP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NLSP as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. NLS Pharmaceutics Ltd’s EPS for the current quarter is expected to be 0.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Instantly NLSP was in red as seen in intraday trades today. With action -1.85%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -24.17%, with the 5-day performance at -1.85% in the red. However, in the 30-day time frame, NLS Pharmaceutics Ltd (NASDAQ:NLSP) is 10.34% up. Looking at the short shares, we see there were 91330.0 shares sold at short interest cover period of 0.95 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -39.99%.
NLSP Dividends
NLS Pharmaceutics Ltd is expected to release its next quarterly earnings report in June.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 18.43% of NLS Pharmaceutics Ltd shares while 10.04% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.31%. There are 10.04% institutions holding the NLS Pharmaceutics Ltd stock share, with BVF INC/IL the top institutional holder. As of 2024-06-30, the company held 15.0543% of the shares, roughly 5.75 million NLSP shares worth $1.25 million.
ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 6.0535% or 2.31 million shares worth $0.5 million as of 2024-06-30.
With 358.0 shares estimated at $576.0 under it, the former controlled 0.01% of total outstanding shares.
